REG - Bunzl PLC - Acquisition

BunzlAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250430:nRSd6827Ga&default-theme=true

RNS Number : 6827G  Bunzl PLC  30 April 2025

 

30 April 2025

 

BUNZL ANNOUNCES ACQUISITIONS IN CHILE AND THE NETHERLANDS

 

Bunzl plc, the specialist international distribution and services Group, today
announces that it has signed an agreement to acquire a business in Chile and
has completed the acquisition of a business in the Netherlands.

 

Bunzl has entered into an agreement to acquire Hospitalia, one of the largest
healthcare distributors in Chile. The business distributes a wide range of
products, including those used in a surgical setting, to both public and
private hospitals. This represents our entry into the healthcare sector in
Chile, with the business generating revenue of CLP 25 billion (c.£21 million)
in 2024. Completion of the acquisition is subject to competition authority
clearance, which is expected in the next few months.

 

Bunzl has also completed the acquisition of Inpakomed, a Dutch business
specialising in sterile product packaging solutions for use in the medical and
forensic markets. The business is highly complementary to our existing
business in the Netherlands and in 2024 generated revenue of EUR 3 million
(c.£2 million).

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer
of Bunzl, said:

 

"Bunzl is a highly cash generative business which allows us to prioritise
investment in self-funded value-accretive acquisitions to drive growth, and
our pipeline remains active. I am pleased to welcome the team from Hospitalia
to Bunzl, with the acquisition marking our expansion into the attractive
Chilean healthcare market, as well as the team from Inpakomed, who will expand
our product and service offering to customers in the Netherlands."

 

Enquiries:

 

 Bunzl plc                                                          Teneo

 Frank van Zanten, Chief Executive Officer                          Martin Robinson

 Richard Howes, Chief Financial Officer                             Giles Kernick

 Sunita Entwisle, Head of Investor Relations and Communications     Tel: +44 (0)20 7353 4200

 Tel: +44 (0)20 7725 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACQILMATMTMTBAA